Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2018. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 17.6B USD
- Positions
- 57
- Share of the ten largest
- 55.4%
The ten largest positions Q4 2018
- Alibaba Group (ADR) 7.9%▲ +7.5%
- Elevance Health 7.6%▲ +6.6%
- Microsoft 7.6%▲ +28.3%
- Amazon 5.7%▲ +258.6%
- Netflix 4.6%▲ +415.3%
- Alphabet Inc. (Class A) 4.6%▲ +1,239.9%
- Visa Inc. 4.6%▲ +390.6%
- Marathon Petroleum 4.4%▲ +85.1%
- United Technologies Corp 4.2%▲ +18.6%
- UnitedHealth Group 4.0%▲ +129.2%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2018
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| BABA Alibaba Group (ADR) | 7.9% | 10,184,489 | 1.4B USD | +7.5% increased | Q1 2018 4 quarters |
| ELV Elevance Health | 7.6% | 5,098,247 | 1.3B USD | +6.6% increased | Q2 2017 7 quarters |
| MSFT Microsoft | 7.6% | 13,172,062 | 1.3B USD | +28.3% increased | Q2 2016 11 quarters |
| AMZN Amazon | 5.7% | 663,784 | 997.0M USD | +258.6% increased | Q2 2015 15 quarters |
| NFLX Netflix | 4.6% | 3,029,736 | 810.9M USD | +415.3% increased | Q3 2015 14 quarters |
| GOOGL Alphabet Inc. (Class A) | 4.6% | 775,969 | 810.9M USD | +1,239.9% increased | Q4 2015 13 quarters |
| V Visa Inc. | 4.6% | 6,130,962 | 808.9M USD | +390.6% increased | Q3 2016 10 quarters |
| MPC Marathon Petroleum | 4.4% | 13,236,261 | 781.1M USD | +85.1% increased | Q2 2018 3 quarters |
| United Technologies Corp | 4.2% | 6,983,646 | 743.6M USD | +18.6% increased | Q3 2017 6 quarters |
| UNH UnitedHealth Group | 4.0% | 2,853,362 | 710.8M USD | +129.2% increased | Q4 2016 9 quarters |
| CRM Salesforce | 4.0% | 5,174,593 | 708.8M USD | +136.9% increased | Q1 2017 8 quarters |
| ADBE Adobe Inc. | 3.6% | 2,781,472 | 629.3M USD | new | Q4 2018 1 quarter |
| META Meta Platforms | 3.6% | 4,796,694 | 628.8M USD | +169.4% increased | Q1 2016 12 quarters |
| Biomarin Pharmaceutical Inc | 2.5% | 5,091,637 | 433.6M USD | +23.3% increased | Q1 2018 4 quarters |
| DIS Walt Disney Company (The) | 2.1% | 3,385,596 | 371.2M USD | −68.8% reduced | Q1 2018 4 quarters |
| ILMN Illumina, Inc. | 2.0% | 1,143,954 | 343.1M USD | +197.0% increased | Q2 2018 3 quarters |
| Liberty Media Corp Delaware | 1.9% | 10,887,257 | 334.2M USD | −3.1% reduced | Q1 2017 8 quarters |
| Dowdupont Inc | 1.8% | 5,850,184 | 312.9M USD | −43.7% reduced | Q2 2018 3 quarters |
| Berry Global Group Inc | 1.5% | 5,517,250 | 262.2M USD | +6.5% increased | Q3 2018 2 quarters |
| MRNA Moderna | 1.5% | 17,081,164 | 260.8M USD | new | Q4 2018 1 quarter |
| Exact Sciences Corp | 1.4% | 3,960,011 | 249.9M USD | +205.9% increased | Q3 2018 2 quarters |
| TMUS T-Mobile US | 1.3% | 3,452,893 | 219.6M USD | +18.2% increased | Q2 2018 3 quarters |
| PGR Progressive Corporation | 1.2% | 3,459,941 | 208.7M USD | +169.0% increased | Q3 2018 2 quarters |
| RJF Raymond James Financial | 1.1% | 2,493,428 | 185.5M USD | −40.2% reduced | Q2 2017 7 quarters |
| American Airls Group Inc | 1.1% | 5,759,432 | 184.9M USD | new | Q4 2018 1 quarter |
| BSX Boston Scientific | 1.0% | 5,201,828 | 183.8M USD | +64.8% increased | Q3 2018 2 quarters |
| BA Boeing | 1.0% | 556,964 | 179.6M USD | new | Q4 2018 1 quarter |
| GOOG Alphabet Inc. (Class C) | 0.9% | 152,714 | 158.2M USD | new | Q4 2018 1 quarter |
| Zillow Group Inc | 0.8% | 4,651,037 | 146.9M USD | new | Q4 2018 1 quarter |
| FANG Diamondback Energy | 0.8% | 1,515,140 | 140.5M USD | new | Q4 2018 1 quarter |
| DVA DaVita | 0.8% | 2,610,629 | 134.3M USD | new | Q4 2018 1 quarter |
| Wellcare Health Plans Inc | 0.8% | 560,418 | 132.3M USD | new | Q4 2018 1 quarter |
| TMO Thermo Fisher Scientific | 0.7% | 547,906 | 122.6M USD | −70.8% reduced | Q4 2017 5 quarters |
| ALGN Align Technology | 0.7% | 561,100 | 117.5M USD | new | Q4 2018 1 quarter |
| Jazz Pharmaceuticals PLC | 0.6% | 916,992 | 113.7M USD | −3.5% reduced | Q1 2017 8 quarters |
| CNC Centene Corporation | 0.6% | 961,252 | 110.8M USD | +57.8% increased | Q2 2018 3 quarters |
| Gallagher Arthur J & Co | 0.5% | 1,200,799 | 88.5M USD | −2.8% reduced | Q1 2018 4 quarters |
| Canadian Pac Ry Ltd | 0.5% | 475,427 | 84.4M USD | new | Q4 2018 1 quarter |
| Zendesk Inc | 0.5% | 1,425,950 | 83.2M USD | new | Q4 2018 1 quarter |
| AON Aon plc | 0.4% | 523,807 | 76.1M USD | +8.5% increased | Q3 2018 2 quarters |
| Syneos Health Inc | 0.4% | 1,756,350 | 69.1M USD | −2.6% reduced | Q1 2018 4 quarters |
| Iqiyi Inc | 0.4% | 4,427,950 | 65.8M USD | +180.6% increased | Q3 2018 2 quarters |
| Blueprint Medicines Corp | 0.4% | 1,200,322 | 64.7M USD | +980.4% increased | Q3 2018 2 quarters |
| Middleby Corp | 0.4% | 620,141 | 63.7M USD | −74.2% reduced | Q2 2018 3 quarters |
| Mylan N V | 0.3% | 1,929,968 | 52.9M USD | −48.6% reduced | Q3 2018 2 quarters |
| Encana Corp | 0.3% | 8,992,541 | 52.0M USD | −87.9% reduced | Q4 2015 13 quarters |
| Catalent Inc | 0.3% | 1,578,431 | 49.2M USD | +5.0% increased | Q1 2018 4 quarters |
| Anaptysbio Inc | 0.3% | 746,037 | 47.6M USD | +22.3% increased | Q1 2018 4 quarters |
| Cognex Corp | 0.2% | 884,422 | 34.2M USD | new | Q4 2018 1 quarter |
| Amneal Pharmaceuticals Inc | 0.2% | 2,353,204 | 31.8M USD | +53.0% increased | Q3 2018 2 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 57 positions.
Breakdown by sector
- Health Care 18.9%
- Communication Services 17.1%
- Technology 15.2%
- Financials 7.3%
- Consumer Discretionary 5.7%
- Energy 5.2%
- Industrials 1.0%
- not in our coverage 29.5%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors